Lataa...
New therapeutic strategies for BRAF mutant colorectal cancers
Oncogenic BRAF mutations are found in ~10% of colorectal cancers (CRCs) and predict poor prognosis. Although BRAF inhibitors have demonstrated striking efficacy in BRAF mutant melanomas, BRAF inhibitor monotherapy is ineffective in BRAF mutant CRC. Over the past few years, studies have begun to defi...
Tallennettuna:
| Julkaisussa: | J Gastrointest Oncol |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4671849/ https://ncbi.nlm.nih.gov/pubmed/26697198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2015.076 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|